Bull market is showing signs of some struggles. Check out high-growth dividend stocks with rapidly growing dividends rather ...

Sees FY25 capital expenditures $1.27B. Sees FY25 effective tax rate 15%-20%. Sees FY25 increase in energy deliveries of 2.5%-3.5%.Maximize Your ...

Pfizer faces revenue decline from patent expirations, profitability challenges, and bearish technicals. Learn why PFE stock ...

Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past ...

These rates apply to your taxable income. Your taxable income is your income after various deductions, credits, and exemptions have been applied. There are also various tax credits, deductions and ...

Since the beginning of 2024, PFE stock has underperformed the S&P 500 index, delivering -3% returns compared to the index’s ...

Real-time index price for TSX Metals and Mining Capped Index (TTMN), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Pfizer Inc. (PFE) is my Top Pick for income-oriented investors in 2025. The past year was unkind to the pharmaceutical giant because it does not have diabetes or weight loss drugs in its portfolio.

Kick off the new school year with stories straight from the classroom! Hear from staff, little learners, and students of all ages as they share their new adventures going into a new year learning.

Earnings season is in full swing in the pharma sector with major players sharing their latest results. On Tuesday (February ...

Stocks are struggling for direction today, and one sector that represents this choppiness is blue-chip drugmakers. Merck & Co ...

The Nikkei Volatility Index, which takes into account the implied volatility of Nikkei 225 options, closed down -5.81% to 23.20. China’s Shanghai Composite Index was closed today for the Lunar New ...